Literature DB >> 28114231

Brief Report About the Role of Hyperthermic Intraperitoneal Chemotherapy in a Prospective Randomized Phase 3 Study in Recurrent Ovarian Cancer From Spiliotis et al.

Philipp Harter1, Alexander Reuss, Jalid Sehouli, Luis Chiva, Andreas du Bois.   

Abstract

A published so-called phase 3 study regarding HIPEC in ovarian cancer raised multiple questions. This commentary focusses on the weakness of the publication and discusses this in detail.

Entities:  

Mesh：

Year:  2017        PMID： 28114231     DOI： 10.1097/IGC.0000000000000864

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN： 1048-891X            Impact factor:   3.437


  12 in total

Review 1.  Narrative review of cytoreductive surgery and intraperitoneal chemotherapy for peritoneal metastases in ovarian cancer.

Authors:  Thomas Boerner; Oliver Zivanovic; Dennis S Chi
Journal:  J Gastrointest Oncol       Date:  2021-04

Review 2.  Intraperitoneal chemotherapy for ovarian cancer with peritoneal metastases, systematic review of the literature and focused personal experience.

Authors:  Federico Coccolini; Paola Fugazzola; Giulia Montori; Luca Ansaloni; Massimo Chiarugi
Journal:  J Gastrointest Oncol       Date:  2021-04

3.  Hyperthermic Intraperitoneal Chemotherapy and Cytoreductive Surgery in Ovarian Cancer: An Umbrella Review of Meta-Analyses.

Authors:  Amine Souadka; Hajar Essangri; Mohammed Anass Majbar; Amine Benkabbou; Saber Boutayeb; Benoit You; Olivier Glehen; Raouf Mohsine; Naoual Bakrin
Journal:  Front Oncol       Date:  2022-05-09       Impact factor: 5.738

4.  A Retrospective Clinical Analysis of Hyperthermic Intraperitoneal Chemotherapy in Gynecological Cancers: Technical Details, Tolerability, and Efficacy.

Authors:  Yagmur Minareci; Ozgur Aydın Tosun; Hamdullah Sozen; Samet Topuz; Mehmet Yavuz Salihoglu
Journal:  Medeni Med J       Date:  2020-09-30

Review 5.  Development of new medical treatment for epithelial ovarian cancer recurrence.

Authors:  Rosanna Mancari; Giuseppe Cutillo; Valentina Bruno; Cristina Vincenzoni; Emanuela Mancini; Ermelinda Baiocco; Simone Bruni; Giuseppe Vocaturo; Benito Chiofalo; Enrico Vizza
Journal:  Gland Surg       Date:  2020-08

6.  Neoadjuvant chemotherapy followed by fast-track cytoreductive surgery plus short-course hyperthermic intraperitoneal chemotherapy (HIPEC) in advanced ovarian cancer: preliminary results of a promising all-in-one approach.

Authors:  Thales Paulo Batista; Vandré Cabral G Carneiro; Rodrigo Tancredi; Ana Ligia Bezerra Teles; Levon Badiglian-Filho; Cristiano Souza Leão
Journal:  Cancer Manag Res       Date:  2017-12-13       Impact factor: 3.989

7.  Selection of patients with ovarian cancer who may show survival benefit from hyperthermic intraperitoneal chemotherapy: A systematic review and meta-analysis.

Authors:  Se Ik Kim; Jaehyun Cho; Eun Ji Lee; Sunwoo Park; Soo Jin Park; Aeran Seol; Nara Lee; Ga Won Yim; Maria Lee; Whasun Lim; Gwonhwa Song; Suk Joon Chang; Jae Won Kim; Hee Seung Kim
Journal:  Medicine (Baltimore)       Date:  2019-12       Impact factor: 1.817

8.  Critical Analysis of Stage IV Epithelial Ovarian Cancer Patients after Treatment with Neoadjuvant Chemotherapy followed by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC).

Authors:  Carlos A Munoz-Zuluaga; Armando Sardi; Michelle Sittig; Vadim Gushchin; Mary C King; Carol Nieroda; Felipe Lopez-Ramirez; Teresa P Diaz-Montes
Journal:  Int J Surg Oncol       Date:  2020-12-16

Review 9.  Hyperthermic intraperitoneal chemotherapy in ovarian cancer: Qui Bono?

Authors:  John Spiliotis
Journal:  Ann Transl Med       Date:  2020-12

10.  Effect of HIPEC on Peritoneal Recurrence in Peritoneal Metastasis Treated With Cytoreductive Surgery: A Systematic Review.

Authors:  Daniel Ren Yi Yap; Jolene Si Min Wong; Qiu Xuan Tan; Joey Wee-Shan Tan; Claramae Shulyn Chia; Chin-Ann Johnny Ong
Journal:  Front Oncol       Date:  2021-12-03       Impact factor: 6.244
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.